Diffusion Weighted Magnetic Resonance Imaging of Brain in Monochorionic Twin Pregnancies With Demise of One Fetus

Sponsor
Peking University Third Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04966039
Collaborator
(none)
60
1
36
1.7

Study Details

Study Description

Brief Summary

Diffusion weighted imaging (DWI) can reflect the microstructure and pathological changes of tissue, and diffusion tensor imaging (DTI) can quantitatively evaluate the fine structure of white matter in brain. In this study, conventional and diffusion-weighted MRI (DWI, DTI) sequences were used to analyze the brain of monochorionic twin pregnancies with demise of one fetus.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention.

Detailed Description

With the incidence rate of twin pregnancy increasing, the incidence of intrauterine death of twin pregnancies is also rising, which has great impact on the morbidity and mortality of the other fetus, and increases the mortality of fetal survival, premature birth, brain damage and long-term sequela. Therefore, it is necessary to examine the central nervous system of the surviving fetus of twin pregnancy and intrauterine death. When the surviving fetus is complicated with nervous system abnormalities, conventional MRI can generally make a diagnosis. However, some of the surviving fetuses may not find other structural or echo abnormalities on B-mode ultrasonography, and even these fetuses do not find structural or signal abnormalities on routine MRI examination. Whether the surviving fetuses may have brain abnormalities cannot be detected early by the above methods. Diffusion weighted imaging (DWI) can reflect the microstructure and pathological changes of tissue, and diffusion tensor imaging (DTI) can quantitatively evaluate the fine structure of white matter in brain.

The present study is to use conventional sequence and diffusion-weighted imaging (DWI, DTI) to analyze the brain of monochorionic twin pregnancies with demise of one fetus, which aims to find the potential brain abnormalities early and provide some guidance for the clinical diagnosis and treatment in the next step.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Diffusion Weighted Magnetic Resonance Imaging of Brain in Monochorionic Twin Pregnancies With Demise of One Fetus
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
monochorionic twin pregnancies with demise of one fetus

Twin pregnancy was diagnosed and one fetus died in utero, 20 pregnant women

Other: No intervention.
There was no intervention.

Twin control group

Twin pregnancy with one abnormal fetus, 20 pregnant women

Other: No intervention.
There was no intervention.

Singleton control group

Singleton pregnancy with abnormalities outside the fetal brain, 20 pregnant women

Other: No intervention.
There was no intervention.

Outcome Measures

Primary Outcome Measures

  1. basic information [baseline]

    age

  2. basic information [baseline]

    gestational age

  3. basic information [baseline]

    uterine height

  4. basic information [baseline]

    abdominal circumference

  5. basic information [baseline]

    intrauterine death time of one fetus

  6. MRI [baseline]

    DWI sequence (ADC value)

  7. MRI [baseline]

    DTI sequence (FA value)

  8. MRI [baseline]

    conventional sequence

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  1. Twin pregnancy was diagnosed and one fetus died in utero

  2. Twin pregnancy with one abnormal fetus

  3. Singleton pregnancy with abnormalities outside the fetal brain

Exclusion Criteria:
  1. Those who can't cooperate with MRI examination, such as those who have metal, claustrophobia or can't insist on scanning.

  2. Pregnant women with gestational age less than 20 weeks.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University Third Hospital Beijing China

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

  • Principal Investigator: Ying Liu, Dr., Peking University Third Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT04966039
Other Study ID Numbers:
  • M2017316
First Posted:
Jul 19, 2021
Last Update Posted:
Jul 19, 2021
Last Verified:
Jun 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Peking University Third Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2021